Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

60 Degrees Pharmaceuticals (SXTP) Enterprise Value (2022 - 2025)

Historic Enterprise Value for 60 Degrees Pharmaceuticals (SXTP) over the last 4 years, with Q3 2025 value amounting to -$4.2 million.

  • 60 Degrees Pharmaceuticals' Enterprise Value rose 1748.61% to -$4.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.2 million, marking a year-over-year increase of 1748.61%. This contributed to the annual value of -$5.2 million for FY2024, which is 13467.32% down from last year.
  • 60 Degrees Pharmaceuticals' Enterprise Value amounted to -$4.2 million in Q3 2025, which was up 1748.61% from -$2.0 million recorded in Q2 2025.
  • 60 Degrees Pharmaceuticals' 5-year Enterprise Value high stood at -$29993.0 for Q1 2023, and its period low was -$5.2 million during Q4 2024.
  • For the 4-year period, 60 Degrees Pharmaceuticals' Enterprise Value averaged around -$2.3 million, with its median value being -$2.1 million (2023).
  • Its Enterprise Value has fluctuated over the past 5 years, first surged by 2070.01% in 2023, then plummeted by 979971.99% in 2024.
  • Over the past 4 years, 60 Degrees Pharmaceuticals' Enterprise Value (Quarter) stood at -$837185.0 in 2022, then crashed by 164.52% to -$2.2 million in 2023, then crashed by 134.67% to -$5.2 million in 2024, then rose by 19.2% to -$4.2 million in 2025.
  • Its last three reported values are -$4.2 million in Q3 2025, -$2.0 million for Q2 2025, and -$3.5 million during Q1 2025.